CD19 CAR T-cell therapy in autoimmune disease—a case series with follow-up F Müller, J Taubmann, L Bucci, A Wilhelm, C Bergmann, S Völkl, M Aigner, ... New England Journal of Medicine 390 (8), 687-700, 2024 | 277 | 2024 |
Validation of the mobile application rating scale (MARS) Y Terhorst, P Philippi, LB Sander, D Schultchen, S Paganini, M Bardus, ... Plos one 15 (11), e0241480, 2020 | 237 | 2020 |
Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course L Cavagna, E Trallero-Araguás, F Meloni, I Cavazzana, J Rojas-Serrano, ... Journal of clinical medicine 8 (11), 2013, 2019 | 189 | 2019 |
German mobile apps in rheumatology: review and analysis using the Mobile Application Rating Scale (MARS) J Knitza, K Tascilar, EM Messner, M Meyer, D Vossen, A Pulla, P Bosch, ... JMIR mHealth and uHealth 7 (8), e14991, 2019 | 164 | 2019 |
Mobile health usage, preferences, barriers, and eHealth literacy in rheumatology: patient survey study J Knitza, D Simon, A Lambrecht, C Raab, K Tascilar, M Hagen, A Kleyer, ... JMIR mHealth and uHealth 8 (8), e19661, 2020 | 159 | 2020 |
CD19-targeted CAR T cells in refractory antisynthetase syndrome F Müller, S Boeltz, J Knitza, M Aigner, S Völkl, S Kharboutli, H Reimann, ... The Lancet 401 (10379), 815-818, 2023 | 143 | 2023 |
2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases A De Thurah, P Bosch, A Marques, Y Meissner, CB Mukhtyar, J Knitza, ... Annals of the rheumatic diseases 81 (8), 1065-1071, 2022 | 116 | 2022 |
68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study C Bergmann, JHW Distler, C Treutlein, K Tascilar, AT Müller, A Atzinger, ... The Lancet Rheumatology 3 (3), e185-e194, 2021 | 88 | 2021 |
Digital rheumatology in the era of COVID-19: results of a national patient and physician survey A Kernder, H Morf, P Klemm, D Vossen, I Haase, J Mucke, M Meyer, ... RMD open 7 (1), e001548, 2021 | 88 | 2021 |
Diagnostic accuracy of a large language model in rheumatology: comparison of physician and ChatGPT-4 M Krusche, J Callhoff, J Knitza, N Ruffer Rheumatology international 44 (2), 303-306, 2024 | 63 | 2024 |
Accuracy, patient-perceived usability, and acceptance of two symptom checkers (Ada and Rheport) in rheumatology: interim results from a randomized controlled crossover trial J Knitza, J Mohn, C Bergmann, E Kampylafka, M Hagen, D Bohr, H Morf, ... Arthritis Research & Therapy 23, 1-7, 2021 | 59 | 2021 |
Efficacy and safety of SARS-CoV-2 revaccination in non-responders with immune-mediated inflammatory disease D Simon, K Tascilar, F Fagni, K Schmidt, G Krönke, A Kleyer, A Ramming, ... Annals of the Rheumatic Diseases 81 (7), 1023-1027, 2022 | 56 | 2022 |
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol P Sen, L Gupta, JB Lilleker, V Aggarwal, S Kardes, M Milchert, T Gheita, ... Rheumatology international 42 (1), 23-29, 2022 | 56 | 2022 |
Advanced machine learning for predicting individual risk of flares in rheumatoid arthritis patients tapering biologic drugs A Vodencarevic, K Tascilar, F Hartmann, M Reiser, AJ Hueber, J Haschka, ... Arthritis research & therapy 23, 1-8, 2021 | 53 | 2021 |
Acceptance of telerheumatology by rheumatologists and general practitioners in Germany: nationwide cross-sectional survey study F Muehlensiepen, J Knitza, W Marquardt, J Engler, A Hueber, M Welcker Journal of medical Internet research 23 (3), e23742, 2021 | 52 | 2021 |
Rescue therapy of antisynthetase syndrome with CD19-targeted CAR-T cells after failure of several B-cell depleting antibodies J Taubmann, J Knitza, F Müller, S Völkl, M Aigner, A Kleyer, R Gary, ... Rheumatology 63 (1), e12-e14, 2024 | 46 | 2024 |
COVAD survey 2 long-term outcomes: unmet need and protocol ZZ Fazal, P Sen, M Joshi, N Ravichandran, JB Lilleker, V Agarwal, ... Rheumatology international 42 (12), 2151-2158, 2022 | 46 | 2022 |
Acceptance, usage, and barriers of electronic patient-reported outcomes among German rheumatologists: survey study M Krusche, P Klemm, M Grahammer, J Mucke, D Vossen, A Kleyer, ... JMIR mHealth and uHealth 8 (7), e18117, 2020 | 46 | 2020 |
Accuracy and tolerability of self-sampling of capillary blood for analysis of inflammation and autoantibodies in rheumatoid arthritis patients—results from a randomized … J Knitza, K Tascilar, N Vuillerme, E Eimer, P Matusewicz, G Corte, ... Arthritis research & therapy 24 (1), 125, 2022 | 43 | 2022 |
Digital health transition in rheumatology: a qualitative study F Muehlensiepen, S Kurkowski, M Krusche, J Mucke, R Prill, M Heinze, ... International Journal of Environmental Research and Public Health 18 (5), 2636, 2021 | 41 | 2021 |